Volume 17, Number 9—September 2011
Research
Seroepidemiologic Study of Pandemic (H1N1) 2009 during Outbreak in Boarding School, England
Table 2
Association of demographic characteristics and interventions with study participants’ reports of ARI during outbreak of pandemic (H1N1) 2009 at a boarding school, England*
Variable |
No. participants |
No. (%) with ARI |
Odds ratio (95% CI) |
---|---|---|---|
Total | 695 | 237 (34.1) | |
Demographics | |||
Category | |||
Students | 469 | 187 (39.9) | 2.53 (1.75–3.65) |
Staff | 226 | 50 (22.1) | 1 |
Age group, y | |||
13–15 | 219 | 75 (34.2) | 1 |
16–18 | 250 | 112 (44.8) | 1.55 (1.06–2.28) |
20–49 | 111 | 32 (28.8) | 0.70 (0.42–1.15) |
>50 | 87 | 18 (20.7) | 0.48 (0.26–0.86) |
Sex, staff only† | |||
F | 109 | 24 (22.0) | 1 |
M | 117 | 26 (22.2) | 0.98 (0.52–1.83) |
Role, staff only | |||
Nonteaching | 135 | 26 (19.3) | 1 |
Teaching |
85 |
23 (27.1) |
1.48 (0.78–2.82) |
Interventions | |||
Took antiviral drugs | |||
No | 198 | 81 (40.9) | 1 |
Yes | 393 | 110 (28.0) | 0.55 (0.38–0.79) |
Use of antiviral drugs: PEP vs. treatment dose | |||
No antiviral drugs | 198 | 81 (40.9) | 1 |
Yes, PEP | 352 | 78 (22.2) | 0.40 (0.27–0.59) |
Yes, treatment dose | 41 | 32 (78.1) | 4.87 (2.20–10.77) |
Completion of PEP course of antiviral drugs† | |||
No antiviral drugs | 198 | 81 (40.9) | 1 |
Not completed | 51 | 14 (27.5) | 0.44 (0.17–1.15) |
Completed | 294 | 62 (21.1) | 0.38 (0.22–0.65) |
Seasonal Influenza vaccine | |||
No | 216 | 66 (30.6) | 1 |
Yes | 425 | 161 (37.9) | 1.35 (0.95–1.92) |
*Categories in which the response was missing or unknown are shown in the Table A1. ARI, acute respiratory infection; CI, confidence interval; PEP, postexposure prophylaxis.
†Excluding those who reported taking the treatment dose of antiviral drugs.